Genetic Therapy for Pancreatic Cancer: Is it the Future?
Journal Title: Pancreas – Open Journal - Year 2018, Vol 2, Issue 1
Abstract
Although surgery is still the only curative therapy for pancreatic cancer, oncological therapies have started to be more and more promising. We firstly have to consider two important points. The first one is that surgery for pancreatic cancer is complex and risky: perioperative mortality is 4-18% and major complications occur in more than 40% of cases.1 Moreover, only 15-20% of patients have a resectable tumour at the first diagnosis.2 Furthermore, disease’s recurrence following operation is very high because of local invasion and micrometastases at the time of surgery.3 The second point is that the first chemotherapies for pancreatic cancer (5-fluoro-uracile, and the actually used, gemcitabine) are not specific for pancreatic tumours and have been provided only a little impact on overall survive.
Authors and Affiliations
Lorenzo Dioscoridi
Keywords
Related Articles
- EP ID EP556708
- DOI 10.17140/POJ-2-e005
- Views 165
- Downloads 0
Evaluation of the Best Power Setting of Laser Waves in Pancreatic Surgery: ECHO ND-YAG Laser Ablation on Bovine Pancreatic Tissue
Background: Pancreatic surgery is one of the most difficult and life-threatening surgical therapy especially during necrotizing pancreatitis and advanced solid neoplasms. Aim of the study: To evaluate the possibility to...
β-cell Heterogeneity: The Key to β-cell Replacement Therapy
Cellular heterogeneity is crucial for organisms to adapt to their environmental changes. It provides the morphological, functional and molecular diversity that allows tissues and organs to respond to stressors and mainta...
Eus-Pancreaticogastrostomy in a Patient with Subtotal Gastrectomy and Roux-En-Y Reconstruction
Chronic Pancreatitis (CP) is often associated with pain due to pancreatic duct obstruction. In these patients, surgical drainage was more effective than endoscopic treatment, achieving a faster, effective, and sustained...
Desmoplastic Reaction in Pancreatic Ductal Adenocarcinoma
Despite significant effort and research funds, Pancreatic Ductal Adenocarcinoma (PDAC) remains one of the deadliest diseases. This cancer is characterized by a distinct desmoplastic reaction that constitutes 80% of the t...
Pancreas: Do All Roads Lead to Mitochondria?
Over several millions of years of evolution, mitochondria have transformed into specialized organelles. Today, they cannot live outside the cell nor can the host cell live without them, resulting in a symbiotic relations...